You just read:

Final Analysis of First-in-Human Phase 1 Study of MM-151 Shows Positive Clinical Activity in Multiple Solid Tumor Types, Including Colorectal Cancer

News provided by

Merrimack Pharmaceuticals, Inc.

06 Jun, 2016, 07:30 ET